Xeris Pharmaceuticals Inc (XERS) — Long-term Investment Intensity
Xeris Pharmaceuticals Inc (XERS) has a Long-term Investment Intensity of 1.1% as of June 2020. Long-term investments of $1.79 Million represent 1.1% of total assets of $165.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. For the complete balance sheet picture, see XERS total asset value.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Xeris Pharmaceuticals Inc Long-term Investment Intensity (2019–2019)
This chart shows how Xeris Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of June 2020, the intensity stands at 1.1%, reflecting long-term investments of $1.79 Million against total assets of $165.81 Million USD. See Xeris Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Long-term Investment Intensity for Xeris Pharmaceuticals Inc (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for Xeris Pharmaceuticals Inc from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Xeris Pharmaceuticals Inc carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 12.1% | $13.23 Million | $108.99 Million | — |